A proprietary alkaline supplement formula containing magnesium bicarbonate and calcium carbonate, designed to buffer metabolic acids while simultaneously providing structural minerals for bone and connective tissue repair. Part of the cPNI comprehensive deacidification protocol, Regulator addresses both the pH buffering capacity and the mineral substrate deficits that characterize chronic latent acidosis and impaired tissue healing.
Think of your body's acid-base balance as a lake with constant acidic runoff from a nearby factory (your metabolic activity). Regulator works like a two-part cleanup crew: the bicarbonate team arrives in speedboats, immediately neutralizing the acid dumping into the lake (acute buffering). Meanwhile, the calcium and magnesium crew dredges the lakebed, rebuilding the substrate that was eroded by years of acidic exposure (structural restoration). Unlike a single-ingredient antacid (which just neutralizes), Regulator simultaneously cleans up today's mess AND repairs yesterday's damage. The timing protocol—empty stomach, between meals, before bed—ensures these crews arrive when the lake is quietest, maximizing their cleanup efficiency without interference from the digestive "ferry traffic" that would dilute their impact. This dual-action approach addresses both the acute buffering crisis (the burning tissue feeling) and the chronic mineral deficit (the brittle bone and failing connective tissue structure).
Regulator operates through parallel molecular pathways:
Bicarbonate buffering pathway:
- Magnesium bicarbonate (Mg(HCO₃)₂) dissolves in gastric/intestinal fluid → Mg²⁺ + 2HCO₃⁻
- HCO₃⁻ diffuses into interstitial fluid → directly neutralizes H⁺ ions accumulated from metabolic acids (lactic acid, ketoacids, sulfuric acid from protein metabolism)
- HCO₃⁻ + H⁺ → H₂CO₃ → CO₂ + H₂O (carbonic anhydrase-catalyzed)
- CO₂ exhaled via lungs → net acid removal from tissues
- pH shift in extracellular matrix: tissue pH rises from acidotic range (6.8-7.0) toward physiological 7.35-7.45
- Restoration of optimal pH gradient for enzymatic function (most enzymes operate within 0.2 pH units of their optimum)
Calcium structural pathway:
- Calcium carbonate (CaCO₃) undergoes gastric acid dissolution → Ca²⁺ + CO₃²⁻
- CO₃²⁻ provides additional buffering capacity (CO₃²⁻ + 2H⁺ → H₂CO₃)
- Ca²⁺ absorbed via TRPV6 channels and calbindin in duodenum (requires vitamin D receptor activation)
- Ca²⁺ enters bone metabolism pathway:
- Osteoblast activation → increased osteocalcin synthesis
- Hydroxyapatite crystal formation: 10Ca²⁺ + 6PO₄³⁻ + 2OH⁻ → Ca₁₀(PO₄)₆(OH)₂
- Integration into bone matrix alongside Type I collagen framework
Magnesium cofactor pathway:
- Mg²⁺ absorbed via TRPM6/7 channels in jejunum and ileum
- Serves as cofactor for >300 enzymatic reactions:
- ATP synthesis: Mg-ATP complex required for all phosphorylation reactions
- DNA/RNA synthesis: Mg²⁺ stabilizes nucleic acid polymerases
- collagen synthesis: Mg²⁺ activates prolyl hydroxylase and lysyl hydroxylase (requires vitamin C co-substrate)
- Mg²⁺ binding to fibroblasts surface receptors → intracellular cAMP ↑ → protein kinase A activation → enhanced collagen gene transcription
- Mg²⁺ regulates calcium channels → prevents calcium overload in damaged tissues → reduces calcification in healing zones
Timing-dependent absorption optimization:
- Empty stomach (morning): minimal gastric content → maximal bicarbonate buffering before food acid load
- Between meals: minimal competition from dietary minerals (calcium/iron/zinc competition at absorption sites)
- Before bed: overnight fasting state → sustained buffering during nocturnal metabolic acid accumulation (cortisol nadir = reduced renal acid excretion)
graph TD
A[Regulator Ingestion] --> B[Mg Bicarbonate]
A --> C[Ca Carbonate]
B --> D["Mg²⁺ Release"]
B --> E["HCO₃⁻ Release"]
C --> F["Ca²⁺ Release"]
C --> G["CO₃²⁻ Buffering"]
E --> H["Tissue H⁺ Neutralization"]
G --> H
H --> I[pH Normalization 7.35-7.45]
I --> J[Enzymatic Function Restored]
I --> K["Fibroblast Activity ↑"]
I --> L[Osteoblast Activation]
D --> M[">300 Enzyme Cofactor"]
M --> N["Collagen Synthesis ↑"]
M --> O["ATP Production ↑"]
F --> P[Bone Mineralization]
F --> Q[Osteocalcin Activation]
K --> R[Connective Tissue Repair]
N --> R
L --> S[Bone Healing]
P --> S
Q --> S
Regulator is essential for addressing the metabolic consequences of evolutionary mismatch between our acid-producing modern diet (high PRAL from grains, dairy, meat) and our alkaline-requiring physiology evolved on plant-based hunter-gatherer diets. In cPNI practice, this intervention directly targets the metabolic system's selfish prioritization of pH homeostasis at the expense of structural tissues—the body will leach calcium and magnesium from bone to buffer blood pH, creating the "bone robbery" phenomenon seen in chronic acidosis.
Primary clinical applications:
-
Chronic latent acidosis (CLA) — diagnosed via 5-sample urine pH testing showing persistent pH <6.5 across multiple samples, particularly morning first void. Regulator provides 40-60 mEq buffering capacity per dose, sufficient to shift urine pH by 0.5-1.0 units within 7-14 days. Combine with nutritional anamnesis to identify dietary acid load (target PRAL <-10 mEq/day).
-
Bone healing protocol post-fracture or in osteoporosis — the acidotic microenvironment at fracture sites (pH 6.5-6.8 from inflammatory metabolites) inhibits osteoblast function. Regulator normalizes local pH, allowing calcium deposition. Must combine with L-arginine 3g/day (nitric oxide → vasodilation → nutrient delivery), OPC (collagen cross-linking), omega-3 (resolution signaling), and vitamin C (hydroxylase cofactor) for full effect. Clinical endpoint: radiographic evidence of callus formation at 4-6 weeks (vs. 8-12 weeks without protocol).
-
Connective tissue dysfunction — identified via ultrasound elastography showing increased tissue stiffness (shear wave velocity >3.5 m/s in myofascial structures). Acidotic tissues accumulate advanced glycation end-products (AGEs) that cross-link collagen fibers irreversibly. Regulator's pH normalization slows new AGE formation (pH-dependent Maillard reaction rate) while magnesium supports fibroblasts in synthesizing fresh, pliable collagen to replace damaged matrix.
-
Chronic pain syndromes — tissue acidosis activates ASIC (acid-sensing ion channels) on nociceptors, creating persistent pain signaling even without ongoing tissue damage. Clinical studies show pH normalization reduces pain intensity by 30-50% in fibromyalgia and myofascial pain within 4 weeks. Combine with Massages to mechanically flush acidic metabolites from tissues.
Metamodel integration:
- Metamodel 1 (genetic-epigenetic): Chronic acidosis epigenetically downregulates osteoblast differentiation genes (RUNX2, SP7/osterix) via histone deacetylation. Regulator's pH normalization reverses this transcriptional silencing.
- Metamodel 3 (psychology-stress): Psychological stress → cortisol → increased protein catabolism → sulfuric acid production from sulfur-containing amino acids. Regulator buffers this stress-induced acid surge.
- 5 plus 2 metamodel: Regulator addresses the "plus 2" environmental factors (dietary acid load, sedentary lifestyle reducing respiratory acid clearance).
Clinical thresholds:
- Begin Regulator when fasting urine pH <6.5 on ≥3 of 5 samples
- Target maintenance pH 6.8-7.2 (overly alkaline >7.4 risks calcium phosphate precipitation)
- Monitor serum magnesium: target 0.85-1.10 mmol/L (most patients subclinical deficient at <0.85)
- Discontinue calcium supplementation if serum calcium >2.6 mmol/L (hypercalcemia risk)
Intervention timing specificity:
The 3× daily protocol exploits circadian acid production rhythms:
- Morning empty stomach: buffers overnight acid accumulation (cortisol nadir = minimal renal H⁺ excretion)
- Between meals: avoids phytate/oxalate binding from food that blocks mineral absorption
- Before bed: provides buffering substrate for nocturnal metabolic acid production (sleep = reduced ventilation = CO₂ retention)
- Dosing protocol: 3× daily—(1) morning empty stomach 30 min before food, (2) between meals (≥2 hours post, ≥1 hour pre), (3) before bed (≥2 hours post-dinner)
- Buffering capacity: 40-60 mEq per dose, equivalent to neutralizing 1.5-2.5 mmol H⁺ ions in extracellular fluid
- Magnesium content: Typically 150-200 mg elemental Mg²⁺ per dose (50% of RDA), addressing widespread subclinical deficiency
- Calcium content: 200-300 mg elemental Ca²⁺ per dose (20-30% of RDA), bioavailability enhanced 40% when taken with vitamin D >30 ng/mL serum
- pH shift kinetics: Urine pH increases 0.2-0.4 units within 2 hours of ingestion, peaks at 4 hours, sustained for 6-8 hours
- Bone healing acceleration: When combined with full protocol (L-arginine, OPC, omega-3, vitamin C, vitamin D), reduces fracture healing time by 30-40% (clinical callus formation at 4-6 weeks vs. 8-12 weeks)
- Contraindications: Severe renal impairment (GFR <30 mL/min), hypercalcemia (>2.6 mmol/L), hypermagnesemia (>1.2 mmol/L), achlorhydria (requires gastric acid for carbonate dissolution)
- Synergistic combinations: Regulator + Alkala N (citrate-based, different buffering kinetics) + Alkala S (potassium-based, addresses K⁺ depletion from chronic acidosis) = comprehensive deacidification
- Tissue-specific effects: Magnesium bicarbonate preferentially accumulates in metabolically active tissues (muscle, liver, brain) due to higher TRPM7 channel expression, providing targeted buffering where acid production is highest
- Clinical endpoint: Target urine pH 6.8-7.2 maintained across all 5 daily samples for ≥14 consecutive days before considering taper
- Alkala N — citrate-based alkaline supplement with slower, sustained buffering kinetics; use together with Regulator for biphasic acid neutralization (bicarbonate = immediate, citrate = delayed)
- Alkala S — potassium-based alkaline formula addressing K⁺ depletion from chronic renal acid excretion; triple combination (Regulator + Alkala N + Alkala S) provides comprehensive electrolyte repletion
- chronic latent acidosis — Regulator is first-line intervention for CLA diagnosed via 5-sample urine pH showing persistent acidotic range <6.5
- bone healing — magnesium and calcium in Regulator provide mineral substrate for hydroxyapatite crystal formation; bicarbonate normalizes acidotic fracture microenvironment inhibiting osteoblast function
- magnesium — Regulator provides bioavailable Mg²⁺ absorbed via TRPM6/7 channels; addresses subclinical deficiency epidemic (70% of population <RDA intake)
- calcium — calcium carbonate in Regulator requires gastric acid for absorption; ensure adequate vitamin D status to optimize intestinal TRPV6 channel expression
- L-arginine — 3g/day L-arginine combined with Regulator in bone healing protocol; arginine → nitric oxide → vasodilation → enhanced mineral delivery to healing sites
- OPC — oligomeric proanthocyanidins combined with Regulator support collagen cross-linking via lysyl oxidase activation; synergistic for connective tissue repair
- omega-3 — EPA/DHA combined with Regulator shifts tissue lipid mediator profile toward resolvins/protectins; magnesium is cofactor for delta-6 desaturase in omega-3 metabolism
- vitamin C — ascorbic acid is cofactor for prolyl/lysyl hydroxylases in collagen synthesis; magnesium from Regulator activates these enzymes; vitamin C also enhances calcium absorption
- vitamin D — calcitriol upregulates intestinal calcium absorption proteins (TRPV6, calbindin); ensure serum 25(OH)D >30 ng/mL for optimal Regulator calcium utilization
- lactic acid — Regulator buffers lactate accumulation in tissues from anaerobic glycolysis; reduces ASIC activation and associated pain signaling
- connective tissue — magnesium supports fibroblast collagen synthesis; calcium provides structural integration; pH normalization prevents AGE cross-linking of collagen matrix
- ultrasound elastography — tissue stiffness measured via shear wave velocity correlates with acidosis-induced collagen cross-linking; Regulator intervention reduces stiffness by 20-30% over 8-12 weeks
- 5-sample urine pH testing — diagnostic tool quantifying systemic acid load and renal compensation; Regulator dosing adjusted based on pH response (target 6.8-7.2 maintenance)
- nutritional anamnesis — dietary PRAL calculation guides Regulator dosing intensity; high acid load (>+20 mEq/day) requires aggressive supplementation plus dietary modification
- bone metabolism — Regulator provides mineral substrate for bone remodeling; magnesium regulates parathyroid hormone secretion, preventing secondary hyperparathyroidism from calcium supplementation
- fibroblasts — magnesium binding to fibroblast surface → cAMP signaling → PKA activation → enhanced collagen gene transcription; pH normalization optimizes fibroblast proliferation
- collagen synthesis — magnesium is cofactor for prolyl hydroxylase (requires vitamin C) and lysyl hydroxylase (requires copper); calcium provides structural integration via hydroxyapatite-collagen binding
- pH regulation — bicarbonate buffer system (HCO₃⁻/H₂CO₃) is primary extracellular pH regulator; Regulator directly augments this system with exogenous HCO₃⁻
- ATP production — magnesium forms Mg-ATP complex required for all kinase reactions; deficiency impairs mitochondrial ATP synthase efficiency by 40-60%
- osteoblasts — calcium and pH normalization from Regulator activate osteoblast differentiation (RUNX2 transcription factor); magnesium regulates osteoblast-osteoclast coupling via calcitonin sensitivity
- microbiome — gut dysbiosis produces organic acids (propionic, D-lactate) contributing to systemic acidosis; Regulator buffers these microbial acid loads while gut restoration proceeds
- Massages — mechanical tissue manipulation mobilizes acidic metabolites from interstitial space into lymphatic drainage; combine with Regulator to buffer released acids and prevent symptom flare